The Medical University of Vienna is a public university located in Vienna, Austria. It is the direct successor to the faculty of medicine at the University of Vienna, founded in 1365 by Rudolf IV, Duke of Austria.

During the past decade, Medical University of Vienna and AKH Cardiology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medical University of Vienna and AKH Cardiology" are "Pulmonary Arterial Hypertension" (3 trials) and "Pulmonary Hypertension" (1 trials). Many other conditions were trialed in "Medical University of Vienna and AKH Cardiology" in a lesser frequency.

Most popular intervention types in "Medical University of Vienna and AKH Cardiology" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Macitentan" (2 trials), "Placebo" (2 trials), "Selexipag" (1 trials), "macitentan (ACT-064992)" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical University of Vienna and AKH Cardiology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Medical University of Vienna and AKH Cardiology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Medical University of Vienna and AKH Cardiology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical University of Vienna and AKH Cardiology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".